The story so far: The Union Health Ministry this past week tightened controls on all fixed-dose combinations (FDCs) containing chlorpheniramine maleate and phenylephrine hydrochloride , requiring manufacturers to carry a clear warning that they must not be used in children below four years of age.
An FDC puts both ingredients into one medicine. Such combinations are commonly encountered in cold/allergy preparations. The government’s action does not mean every medicine containing either ingredient individually has been banned. The specific regulatory action concerns FDCs containing the two ingredients together. The government’s Expert Committee and Drugs Technical Advisory Board (DTAB) concluded that these combinations could pose risks to children below four and that safer alternatives are available. Not necessarily. These drugs can relieve symptoms, but they don’t cure the underlying viral infection. Most childhood colds resolve on their own. What doctors have been saying is that while parents may understandably want to make a congested or coughing child comfortable, but more medication isn’t automatically better. The key message is don’t self-medicate a child under four with a chlorpheniramine + phenylephrine combination, even if the product is marketed as a children’s cold medicine. Check the active ingredients, not just the brand name. Many cold preparations contain several ingredients, creating a risk of accidentally giving the same drug twice through different products.
